Nationwide Fund Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Nationwide Fund Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-68,928	Closed	-$2.95M	–	2630
2017 Q3	$2.95M	Buy	68,928 +59,199	+608%	+$1.89M	0.01%	1278
2017 Q2	$127K	Buy	9,729 +2,591	+36%	+$34.1K	﹤0.01%	2812
2017 Q1	$94K	Hold	7,138	–	–	﹤0.01%	2862
2016 Q4	$92K	Hold	7,138	–	–	﹤0.01%	2898
2016 Q3	$117K	Hold	7,138	–	–	﹤0.01%	2837
2016 Q2	$89K	Buy	7,138 +2,694	+61%	+$33.7K	﹤0.01%	2955
2016 Q1	$48K	Buy	4,444 +1,134	+34%	+$10.3K	﹤0.01%	2990
2015 Q4	$49K	Buy	+3,310	New	+$40.5K	﹤0.01%	2997

Other funds holding MYOK

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Nationwide Fund Advisors's MYOK Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2017, closing a stake of 68,928 shares — an estimated $2.95M sold.

Nationwide Fund Advisors first reported a position in MYOK in Q4 2015 and held it in 8 quarters. The position peaked at $2.95M in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q4 2017.

Nationwide Fund Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 68,928 MyoKardia, Inc. Common Stock shares in Q4 2017, an estimated $2.95M.
Nationwide Fund Advisors first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 8 quarters.
Nationwide Fund Advisors's MyoKardia, Inc. Common Stock position peaked at $2.95M in Q3 2017.
121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.